Be a Smart Investor
Wednesday, March 8, 2017
Novo Nordisk in bid for Global Blood Therapeutics
Novo Nordisk has approached Global Blood Therapeutics, a U.S. biotechnology company focused on serious blood disorders, to discuss a potential acquisition.
from Mergers and Acquisitions http://ift.tt/2mjrKAo
No comments:
Post a Comment
Newer Post
Older Post
Home
View mobile version
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment